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Abstract
Introduction: Patients presenting with cirrhosis and hepatic tumours represent a fragile group that have
typically been avoided in early series of laparoscopic liver resection. This study was undertaken to
evaluate the results of a laparoscopic hepatectomy in the setting of cirrhosis.
Methods: Subgroup analysis of patients with cirrhosis within a series of 327 patients undergoing a
laparoscopic resection was performed. Comparisons were made with patients without cirrhosis where
appropriate to highlight differences in patient selection and outcomes. Specific variables assessed
included operative details and short-term outcomes including length of stay (LOS), morbidity and
mortality. Outcomes specific to hepatocellular carcinoma (HCC) were also assessed.
Results: There were 52 patients with cirrhosis undergoing a laparoscopic hepatic resection. Ninety per
cent of patients were Childs class A, with a median model for end-stage liver disease (MELD) score of 8.
Hepatitis C was the most common cause of cirrhosis (88.5%), whereas the most common indication for
an operation was HCC (71.2%). Resections were generally limited, with the median number of segments
resected being 2 (range: 1–4). Complications occurred in 13 (25%) patients, with a 90-day mortality of
5.8%. The median LOS was 3 days.
Conclusions: A laparoscopic hepatectomy is safe in the setting of cirrhosis, provided the application of
appropriate selection criteria and sufficient experience with the procedure.
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Introduction
In the ensuing decade and a half since the first report of a laparo-
scopic liver resection in 1994,1 great strides have been made in the
field. Early series were small and limited primarily to patients with
small lesions located in the peripheral segments of the liver.2,3 As
multiple centres worldwide have gained increasing experience
with minimally invasive hepatic surgery, more difficult operations
are being performed laparoscopically, including a hepatic
lobectomy,4–7 resection of tumours in the posterior and superior
segments of the liver,8–10 and a laparoscopic redo hepatectomy.11,12
A hepatic resection in the setting of cirrhosis adds an extra
degree of difficulty. Intra-abdominal varicies, impaired coagula-
tion, a firm liver parenchyma less amenable to transection tech-
niques such as stapling, and the specter of post-operative hepatic
insufficiency are all potential contributors to the greater treachery
of hepatic surgery in a cirrhotic population. In spite of these
challenges, experienced centres worldwide are beginning to amass
greater experience with laparoscopic resections in patients with
cirrhosis. Results from the overall series of patients undergoing a
laparoscopic liver resection by this group of authors have recently
been reported.13 The overwhelming majority (86%) of patients in
that report did not have underlying cirrhosis. Thus, there remains
a possibility that there may have been less than favourable out-
comes in the population of patients with cirrhosis that was not
reflected in the overall analysis because they were masked by the
satisfactory outcomes in the larger cohort of patients with cirrho-
sis. Given the markedly increased risk of performing a laparo-
scopic liver resection in the setting of cirrhosis, a subset analysis is
This manuscript was presented at the 10th World IHPBA Congress, Paris,
1–5 July 2012.
DOI:10.1111/hpb.12098 HPB
HPB 2014, 16, 164–169 © 2013 International Hepato-Pancreato-Biliary Association
necessary to determine whether such procedures are indeed safe in
this population of patients. The goal of the current manuscript is
to evaluate outcomes in the subset of patients undergoing a resec-
tion in the setting of cirrhosis.
Methods
With Institutional Review Board Approval, a retrospective review
of 327 consecutive patients undergoing a laparoscopic liver resec-
tion by a single group of surgeons over a greater than 10-year
period was performed. Patient characteristics, outcomes and the
learning curve for the first 300 patients as a whole have been
previously described.13 The present study represents a subgroup
analysis of the cirrhotic patients in the series in terms of baseline
characteristics, indications for operation, operative details and
peri-operative outcomes. Hepatic synthetic function was deter-
mined using the Child–Pugh classification and model for end-
stage liver disease (MELD) score. The American Society for
Anesthesiologists (ASA) classification was used as a surrogate for
overall morbidity. Comparisons were made with the cohort of
patients without cirrhosis where appropriate to illustrate differ-
ences in patient selection. Continuous covariates were summa-
rized as median (range) and compared with theWilcoxon–Mann–
Whitney test, whereas categorical covariates were summarized as
count (percentage) and compared using the chi-squared or Fish-
er’s exact test, where appropriate. Univariable analysis of factors
associated with post-operative complications in the group of
patients with cirrhosis was performed using logistic regression.
Multivariable analysis was not performed as the limited sample
size in the study would make such an analysis prone to bias result-
ing from overfitting, and thus not applicable to a more general
population. All statistical analyses were performed using SAS
Version 9.3 (SAS Institute, Cary, NC, USA) and P < 0.05 was
considered significant.
Pre-operative workup of cirrhotic patients
Pre-operative determination of fitness for the operation began
with a complete history and physical examination, as well as deter-
mination of relevant laboratory parameters. Items particularly
sought were those indicating significant portal hypertension such
as oesophageal varices, ascites and thrombocytopenia. Hepatic
function was determined using the Child–Pugh classification and
MELD score. With only a few exceptions, only Child A patients
were considered suitable candidates, whereas Child C status rep-
resented a contraindication for a hepatic resection.
Imaging evaluation typically consisted of triple phase com-
puted tomography for lesion characterization as well as operative
planning. Magnetic resonance imaging was used in the minority
of patients. A future liver remnant of 30–40% was sought, with
greater percentages left for those with less well compensated liver
function. Computed tomography volumetry was used on a case-
by-case basis when there was concern for a potentially marginal
future liver remnant. ICG-9 clearance was not used to determine
hepatic function. Portal vein embolization was also not used. In
addition to general medical fitness to undergo a laparotomy and
adequately compensated liver function as outlined above, criteria
for resectability included the ability to resect all tumours bearing
parenchyma while preserving a future liver remnant of 30–40%.
Results
Baseline patient characteristics
There were a total of 327 patients included in the study, of whom
52 (16%) had cirrhosis. Baseline characteristics of those with and
without cirrhosis are shown in Table 1. The final pathology on the
benign lesions in those patients with cirrhosis included two regen-
erative nodules, four bile duct hamartomas, one haemangioma
and undetermined in one patient. All resections in the group of
patients with cirrhosis were performed based on a suspicion of
malignancy.
Operative details and short-term outcomes
Operative details and short-term outcomes are shown in Tables 2
and 3. Five of the deaths have been previously described in detail,13
and included two deaths resulting from post-operative bleeding,
two deaths from sepsis with multiple organ failure and one death
from a pulmonary embolus. The remaining death was in a patient
with cirrhosis who died of sepsis 2 months post-operatively. Uni-
variate analysis of complications in the cohort with cirrhosis
revealed age, lesion size, number of segments resected, operative
length and blood loss all to be positively correlated with the devel-
opment of a post-operative complication (Table 4).
HCC-specific outcomes
There were 37 patients with cirrhosis undergoing a laparoscopic
resection forHCC,with amedian follow-up of 24.7months (range
0.2–91.8). The median tumour size was 2.8 cm (1.0–8.3). The
medianmargin width was 1.0 cm (0.1–2.0).Nine (24.3%) patients
with cirrhosis and HCC had margins less than 0.5 cm in width.
Only one patient developed recurrence, which was intrahepatic,
and subsequently died 11 months post-operatively. The margin
width in this patient was 2 cm. The overall survival at 1 and 3 years
for the HCC cohort was 85.2% and 71.0%, respectively.
Discussion
The majority of reports of a laparoscopic hepatic resection in
patients with cirrhosis in the world literature come from either
series on HCC or on general laparoscopic liver resection series14–21
(Table 5). Typical criteria for a laparoscopic approach in these
series has been peripheral tumour location with a size of under
5 cm.15,16,21,22 A size limit of 5 cm or less was once a common
requirement in many laparoscopic centres, although, as experi-
ence has built this limitation is disappearing.14 The authors no
longer consider tumour size to be an absolute indication for a
laparoscopic or open operation in most patients.
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In the two reports where data are available, it is seen that a
laparoscopic major hepatectomy is only performed for a small
minority of patients with cirrhosis, including 6% in Belli’s series
and 3.7% in Cherqui’s series.15,16 This bias towards a limited resec-
tion is confirmed in the current series, in which the large majority
of operations were either segmentectomies or left lateral segment
Table 1 Baseline patient characteristics
Cirrhosis (n = 52) No cirrhosis (n = 275) P-value
Age (years) 60 (40–81) 54 (18–91) 0.002
ASA Class 3.3  0.2 2.7  3.0 <0.001
Class 2 0 (0.0%) 90 (32.7%)
Class 3 34 (65.4%) 175 (63.6%)
Class 4 18 (34.6%) 10 (3.6%)
BMI (kg/m2) 27 (20–42) 27 (14–47) 0.503
History of diabetes 18 (34.6%) 51 (18.6%) 0.009
History of hypertension 42 (80.8%) 111 (40.4%) <0.001
History of previous hepatectomy 0 (0.0%) 17 (6.2%) 0.066
INR 1.1 (0.9–2.20) 1 (0.9–1.4) <0.001
Creatinine (mg/dl) 0.9 (0.4–1.9) 0.7 (0.3–2.2) <0.001
Bilirubin (mg/dl) 0.6 (0.3–2.8) 0.5 (0.2–1.3) 0.001
Platelet count (103 platelets) 141 (41–455) 240 (100–587)
Pathology <0.001
Benign 8 (15.4%) 169 (61.4%)
Primary hepatic malignancy 40 (76.9%) 31 (11.3%)
Colorectal metastasis 3 (5.8%) 43 (15.6%)
Non-colorectal metastasis 1 (1.9%) 32 (11.6%)
Median (range) size of the lesion (cm) 2.5 (0.5–8.3) 4.5 (0.4–20.0) <0.001
MELD score 8 (6–15) n/a
Child–Pugh classification
Class A 47 (90.4%) n/a
Class B 5 (9.6%) n/a
Cause of cirrhosis
Hepatitis B 2 (6.9%) n/a
Hepatitis C 46 (88.5%) n/a
NASH 4 (7.7%) n/a
Ascites present 8 (15.4%) n/a
Varices present 15 (28.9%) n/a
Continuous values are presented as median (range).
BMI, body mass index; INR, International Normalized Ratio; MELD, model for end-stage liver disease; NASH, non-alcoholic steatohepatitis.
Table 2 Laparoscopic hepatic resections performed in patients with
cirrhosis
Segmental resection 36 (69.2%)
Left lateral segmentectomy 11 (21.2%)
Left hepatectomy 2 (3.8%)
Right hepatectomy 1 (1.9%)
Central hepatectomy 2 (3.8%)
Table 3 Comparison of operative and post-operative outcomes in
patients with and without cirrhosis
Cirrhosis No cirrhosis P-value
Segments resected 2.0 (1–4) 2.0 (1–6) <0.001
OR time (hours) 2.0 (1–6) 2.5 (0.5–7) 0.019
Blood loss (ml) 100 (50–1500) 150 (0–1500) 0.254
Transfused 8 (15.4%) 15 (5.5%) 0.011
Complications 13 (25.0%) 48 (17.5%) 0.200
Length of stay (days) 3 (0–16) 3 (1–17) 0.503
90-day mortality 3 (5.8%) 3 (1.1%) 0.054
Continuous values are presented as median (range), while categorical
values are presented as count (percentage).
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resections, and the median number of segments resected was only
2. It has been a feature of many laparoscopic liver resection series
to demonstrate a bias towards smaller, more straightforward
resections.23 This bias is, in the authors’ opinion, an unavoidable
result of the learning curve inherent in laparoscopic hepatic
surgery, in which the more accessible lesions are approached first
prior to undertaking more difficult resections. Given the relatively
infancy of laparoscopic liver resection, these early experiences are
likely to dominate most series for the near future.
When undertaken by surgeons with the appropriate experience,
however, the results obtained with a laparoscopic resection in
patients with cirrhosis have been excellent. Morbidity in the series
above range from 6% to 55.6%17,22 with a such great variation
probably resulting from the reporting of minor complications.
The 25% morbidity in the current series was not significantly
greater than that in the patients without cirrhosis this is in spite of
a more frail patient population as evidenced by greater age,
comorbidities and ASA classification. Mortality in the current
series was 5.8%, which is somewhat higher than the 0%–2% rates
reported in the above series.14–17,19,22
Some of this difference results from the fact that in the present
study 90-day mortality was reported compared with the 30-day
figure quoted in many earlier series. A recent review of national
data in the United States by Mayo et al.24 has demonstrated a
greater than 5% increase in 90-day mortality compared with
30-day mortality after \ hepatic resection for HCC, and has
defined 90-day mortality as the new standard in reporting for
hepatic surgery. The overall 90-day mortality rate after a hepatic
Table 4 Univariate analysis of complications after laparoscopic hepatic resection in patients with cirrhosis
Covariate Odds Ratio Lower 95% CI Upper 95% CI P-value
Age (years) 1.11 1.03 1.20 0.008
Body Mass Index (kg/m2) 0.94 0.81 1.09 0.400
Size of Mass (cm) 1.81 1.16 2.82 0.009
INR 0.75 0.02 36.17 0.886
Creatinine (mg/dl) 1.40 0.21 9.23 0.729
Bilirubin (mg/dl) 2.87 0.60 13.70 0.185
Platelet Count 1.00 1.00 1.01 0.337
Ascites Present 2.04 0.41 10.06 0.381
Varices Present 1.81 0.48 6.85 0.380
Child's Class B (versus Class A) 5.55 0.81 37.88 0.080
MELD Score 1.08 0.82 1.41 0.593
ASA Class 4 (versus Class 3) 1.93 0.53 6.97 0.316
Hand Assisted (versus Pure Laparoscopy) 2.86 0.78 10.43 0.112
Segments Resected 3.28 1.38 7.77 0.007
OR Time (hours) 2.65 1.21 5.79 0.015
Blood Loss (ml) 1.00 1.00 1.01 0.004
Odds ratios represent an increase or decrease in the odds of a complication for each one unit increase for continuous variables, or for the presence
of categorical variables in comparison to the indicated baseline variable. Multivariate analysis was not performed because of the limited sample size.
Table 5 Selected series containing a laparoscopic hepatic resection in patients with cirrhosis
Author Location Number of patients
with cirrhosis
% major
resections
Morbidity Mortality
Belli Italy 54 6% 19% 2%
Chen Taiwan 116 – 6% 0%
Cherqui France 27 3.7% 33% 0%
Dagher Multinational European 120 – – 1.7%
Gigot Multinational European 9 – 55.6% 0%
Koffron USA 25 – – –
Lai Hong Kong 23 – 16% 0%
Sarpel USA 9 – – –
‘–’ indicates an inability to calculate these data for the patients with cirrhosis from the information given in the manuscript.
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resection quoted in Mayo’s series was 15.0%.24 Details on the
deaths in the current series have been reported previously,13 where
it was noted that two of the deaths occurred after difficult resec-
tions in patients with cirrhosis early in the learning curve, again
underscoring the importance of gradual progression from small
peripheral lesions requiring a limited resection to less accessible
lesions requiring a more extensive resection.
Although no randomized controlled trials have been reported
to provide conclusive evidence, a laparoscopic resection has a
number of theoretical benefits specific to the population of
patients without cirrhosis. Theoretically, more limited incisions
result in less disruption of the abdominal wall collateral circula-
tion and less fluid shifts from exposure of the peritoneal cavity. It
the authors’ anecdotal experience that the pneumoperitoneum
utilized in laparoscopy may exert a tamponade effect on bleeding
from intra-abdominal varices, which are a low pressure system,
although experimental evidence to confirm this suspicion is
lacking. Finally, Laurent et al. 25 have demonstrated that a subse-
quent liver transplantation is less difficult in patients who have
undergone a previous laparoscopic compared with an open resec-
tion of HCC, which may be attributable to a lesser burden of
post-operative adhesions.
Cirrhosis represents an additional degree of difficulty over a
laparoscopic liver resection in patients with normal underlying
hepatic parenchyma. In spite of the less invasive nature of this
approach, general patient selection criteria in terms of hepatic
function,medical fitness and future liver remnant should be iden-
tical to those used for an open resection. For programmes early in
the learning curve, for a laparoscopic resection adoption of addi-
tional criteria are recommended. Initially, lesions laparoscopically
resected should be in the more accessible left or anterior right
segments of the liver. An initial size limitation of 5 cm is also
recommended. As greater experience is accrued, the indications
for laparoscopic resection will gradually become identical to those
for open resection. By following such a gradual and progressive
approach, excellent outcomes can be attained with a laparoscopic
hepatic resection in the setting of underlying cirrhosis.
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